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Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), expressed on P. falciparum-infected erythrocytes, is a ma-
jor family of clonally variant targets of naturally acquired immunity to malaria. Previous studies have demonstrated that in ar-
eas where malaria is endemic, antibodies to infected erythrocytes from children with severe malaria tend to be more seropreva-
lent than antibodies to infected erythrocytes from children with nonsevere malaria. These data have led to a working hypothesis
that PfEMP1 variants associated with parasite virulence are relatively conserved in structure. However, the longevity of such
serologically conserved variants in the parasite population is unknown. Here, using infected erythrocytes from recently sampled
clinical P. falciparum samples, we measured serological conservation using pools of antibodies in sera that had been sampled 10
to 12 years earlier. The serological conservation of infected erythrocytes strongly correlated with the expression of specific
PfEMP1 subsets previously found to be associated with severe malaria. However, we found no association between serological
conservation per se and disease severity within these data. This contrasts with the simple hypothesis that P. falciparum isolates
with a serologically conserved group of PfEMP1 variants cause severe malaria. The data are instead consistent with periodic
turnover of the immunodominant epitopes of PfEMP1 associated with severe malaria.
Malaria is still a major cause of childhood illness and death inAfrica. However, repeated exposure to infection results in
the acquisition of naturally acquired immunity (1), underpinning
ongoing efforts to develop effective vaccines and other interven-
tions. Immunity to severe malaria, which accounts for the bulk of
deaths from malaria, develops relatively rapidly, while that to
nonsevere disease may take many years to develop (1, 2). This
suggests the existence of a relatively conserved set of targets of
natural immunity among parasites causing severe disease. Sup-
port for this idea comes from observations that naturally acquired
antibodies tend to recognize variant surface antigens (VSAs) on
infected erythrocytes (IEs) from children with severe malaria
more frequently than they recognize VSAs on IEs from children
with nonsevere malaria (3–5), suggesting that parasite antigens on
the IEs might account for the distinct rates of acquisition of im-
munity to these clinical manifestations. These commonly recog-
nized, serologically conserved VSAs have been called VSAFoRH
(VSAs for which the frequency of recognition is high) (6) and
VSASM (VSAs for severe malaria) (7).
Plasmodium falciparum erythrocyte membrane protein 1
(PfEMP1), an extremely diverse group of multidomain parasite
molecules encoded by var genes (8), is thought to be the major
parasite antigen on IEs and mediates IE binding to the host mi-
crovascular endothelium, resulting in parasite sequestration in
host tissues and the multiorgan pathology associated with severe
malaria. There is good evidence that PfEMP1 molecules are key
targets of naturally acquired immunity to malaria (9, 10). How-
ever, PfEMP1 variants elicit a predominantly variant-specific an-
tibody response (11), which, together with their extreme sequence
diversity, raises the question of whether PfEMP1 molecules can
underlie the relatively rapid acquisition of immunity to severe
malaria. One model is that parasite virulence is linked to the ability
of PfEMP1 molecules to adhere effectively to host cells and that
this function in turn imposes constraints on antigenic diversity so
that the best host cell binders are also the first to elicit host anti-
body responses. There is reasonable support for such an idea.
First, a subgroup of PfEMP1 molecules, called group A, was
found in in vitro selection experiments to be well recognized by
pools of IgG from malaria parasite-exposed children (7). The rel-
ative conservation of this group of PfEMP1 molecules is sup-
ported both through sequence analysis (12, 13) and through sero-
logical analysis of recombinant proteins (14). Second, group A
PfEMP1 molecules have been found to be more commonly ex-
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pressed by clinical isolates from children with severe malaria and
low host immunity (15–19). Similar observations have recently
been made for PfEMP1 molecules carrying a specific structural
signature, or domain cassette (DC). PfEMP1 molecules carrying
DC8 carry conserved epitopes and are associated with severe ma-
laria (18, 20).
However, despite these data, it is still not clear whether severe
malaria and VSASM (15) can be linked through a single set of
serologically conserved PfEMP1 variants. This is because these
previous studies have focused on either (i) crude serological asso-
ciations of frequently recognized IEs with severe malaria (3–5),
(ii) associations between specific PfEMP1 subgroups and sero-
prevalence (7, 14, 21, 22), or (iii) specific PfEMP1 subgroups and
severe malaria (15–17, 19, 23–25). We therefore sought to test
simultaneously the associations among the var gene transcription
profiles of clinical parasite isolates from Kenyan children, the
strength of recognition of erythrocytes infected by these parasites
by sera from children in the same setting, and severe disease.
MATERIALS AND METHODS
Study participants andparasite sampling.This work utilized a published
var gene sequence data set (15), a quantitative PCR data set (27), and
clinical isolates sampled from corresponding children presenting with
malaria to Kilifi County Hospital in Kilifi, Kenya, between 2005 and 2007
(15). Sampling was done following the receipt of ethical approval from the
Kenya Medical Research Institute Ethical Review Committee and in-
formed consent from the study participants’ parents or guardians (15, 19).
Standard definitions of severe malaria based on parasitemia and clinical
symptoms were used (15). Parasite cDNA was generated from uncultured
ring-stage parasites sampled from children at the time of presentation to
the hospital. This was used to generate var sequence data by classifying
and counting the number of expressed sequence tags (ESTs) as described
previously (15, 26) and by quantitative PCR using published primers and
methods (18). For the EST approach, parasite cDNA was subcloned into
bacterial cells, and up to 96 colonies of each parasite isolate were se-
quenced (15, 26). Following quality control of the sequence data, the
number of individual colonies of each isolate carrying Cys2 and group
A-like sequence types was expressed as a percentage and used for analysis
(15, 26). Group A-like sequence types were defined here using a collection
of polymorphic sequence blocks that distinguishes known group A
PfEMP1 variants from non-group A PfEMP1 variants with high specific-
ity and sensitivity (15). For the quantitative PCR approach, the transcript
abundance of each var gene subset in each parasite isolate was determined
and used for the analysis, as described previously (18). A published quan-
titative PCR data set was used for the analysis (27) and these attempts to
measure the expression levels of (i) group A PfEMP1 (primers DBLa1 not
var3, DBLa2/a1.1/2/4/7, and CIDRa1.6), (ii) DC8 PfEMP1 (primers CI-
DRa1.1, DBLa_CIDRa, DBLb12 and DBLb3/5, and DBLg4/6), (iii) DC13
and DC9 PfEMP1 (primers CIDRa1.4 and DBLz4, respectively), and (iv)
group B and C PfEMP1 (primers B1 and C2, respectively) (17, 18).
Measurement of the ability of IEs to be recognized by serum and
plasma antibodies (serological conservation).To determine the serolog-
ical conservation of antigens expressed on IEs, we used sera from 800
healthy children aged 1 to 4 years sampled as part of a large cross-sectional
survey conducted in 1995 (9, 28) and a set of parasite isolates sampled 10
to 12 years afterwards (2005 to 2007) (15). This ensured that our measure
of serological conservation did not merely reflect the seroprevalence of
antibodies to PfEMP1 variants that were commonly circulating at the time
of sampling of the clinical parasite isolates. Four hundred of these serum
samples were from children with detectable P. falciparum infection at the
time of sampling, and the rest were from those without detectable para-
sites; all samples were evaluated for P. falciparum infection by light mi-
croscopy. To maximize the chances of detecting antibody specificities that
were common in most children while diluting those that were rare, we
made pools of sera for each of four age categories, that is, 1, 2, 3, and 4
years of age. For each age group, a pool of sera from 100 children without
infection (parasite negative) was made and another pool of sera from 100
children with infection (parasite positive) was made. To identify parasite
isolates expressing serologically conserved antigens, the reactivity of the
IgG antibodies in these 8 pools against 92 parasite isolates from children
with severe malaria (n 47) or nonsevere malaria (n 45) was tested by
immunofluorescence assay (IFA) of live IEs quantified by flow cytometry.
The following additional assays were performed for comparison: (i) a
subset of the parasites was tested for reactivity with these serum sample
pools by an agglutination assay, and (ii) parasite isolates were tested for
reactivity with a panel of 15 previously described plasma samples from
children with acute malaria collected in the study setting between 1994
and 1996 by both IFA and an agglutination assay (3).
To assay the recognition of parasites by serum and plasma antibodies,
ring-stage parasite isolates were cultured using standard methods to reach
the mature trophozoite stage, when PfEMP1 is expressed on the IEs, and
then cryopreserved in liquid nitrogen until the day of assay. To measure
the strength of recognition of IEs by antibodies in the serum and plasma
samples, IEs were thawed and adjusted to a maximum of 2% parasitemia
using blood group O erythrocytes from a single donor. Total IgG binding
to the IEs was then measured as described previously (19), and the mean
fluorescence intensity (MFI) for each serum sample pool or plasma sam-
ple panel was acquired. All samples in the serum sample pools and the
plasma sample panel were from individuals with blood group A (3, 28),
which allowed assessment of IE recognition only for children with blood
groups A and O. Agglutination assays were performed essentially as de-
scribed previously (3), but with some modifications. Briefly, for each iso-
late, a 4% hematocrit of the thawed trophozoite-infected erythrocytes
(which had been used for flow cytometry) was prepared in 11.5 l phos-
phate-buffered saline containing 0.5% bovine serum albumin and 1 l of
test plasma in 96-well plates. Following rotation on a vertical rotor for 1 h,
the cell suspension was transferred onto microscope slides, fixed with
methanol, air dried, and stained with 5 g/ml acridine orange. Scoring
was done under a fluorescence microscope (Eclipse 80i; Nikon, Japan),
and an agglutinate was defined as a clump of 5 intact trophozoite-in-
fected erythrocytes. The number of agglutinates falling into each of four
categories (size A,5 to 25 IEs; size B,25 to 125 IEs; size C,125 to 625
IEs; size D, 625 IEs) was counted, and a conservative estimate of the
number of IEs in agglutinates of each size category was determined by
multiplying the total number of agglutinates in that size category by the
lower limit of the number of IEs defining that size category. Thus, for each
isolate, the number of size A clumps was multiplied by 5, the number of
size B clumps was multiplied by 26, the number of size C clumps was
multiplied by 126, and the number of size D clumps was multiplied by
626. The sum of the estimated number of IEs in the four size categories
(here termed “agglutination score”) was then used for the analysis.
Statistical analysis. Stata software (v11) was used for all statistical
analyses, and GraphPad Prism software (v6) was used for graphical rep-
resentation of the data. Spearman’s rank correlation coefficient was used
to assess the relationship between var expression and the strength of rec-
ognition of IEs by antibodies in the serum sample pools (see Fig. 1b).
Unadjusted logistic regression models were used to assess the associations
between severe malaria and the strength of IE recognition (see Fig. 1c) and
between severe malaria and var expression levels (see Fig. 1d). Each anti-
body or var expression measure was used to predict disease severity, and
the odds ratios were plotted (see Fig. 1c and d). Disease severity was used
as a binary variable, while both IE recognition (i.e., levels of IgG antibody
to IE; see Fig. 1c) and var expression levels (see Fig. 1d) were used as
continuous variables. In these analyses, quantitative PCR data were log
transformed, whereas arcsine transformation was used for the EST anal-
ysis (15). Statistical significance was based on the conventional alpha
value of 0.05, and the Bonferroni correction for multiple comparisons was
performed where indicated. All the raw data used in the analyses are pre-
sented in Data Set S1 in the supplemental material.
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RESULTS AND DISCUSSION
Consistent with the findings of previous studies, the antibody re-
sponses in the serum sample pools measured using IFA were gen-
erally higher among parasite-positive children than children in
whom the parasite was not detectable (28, 29) and increased with
age (Fig. 1a). Overall, the proportion of the 92 isolates recognized
by antibodies was greater for the pools of serum from parasite-
positive children than the panel of 15 individual plasma samples
from children presenting with nonsevere malaria (Fig. 1a; see also
Fig. S1 in the supplemental material). A higher proportion of par-
asites was recognized by IFA than by agglutination (see Fig. S1 in
the supplemental material). This supported the use of IFA detec-
tion of IgG in the serum sample pools to identify IE surface anti-
gen epitopes that were present within the local parasite population
both at the time of serum sampling and at the time of parasite
sampling.
We related the recognition of the 92 parasite isolates by these
serum sample pools to their corresponding var gene expression
profiles using two approaches: (i) an expressed sequence tag (EST)
approach that involved cloning and sequencing of PCR-amplified
var sequence tags, which allows assessment of the relative number
of group A-like genes expressed by classifying and counting the
sequences amplified using a set of universal primers to the DBL
region of PfEMP1 (26, 30), and (ii) a quantitative PCR approach
using a set of primers mostly directed toward PfEMP1 domain
cassettes (DCs), including DC8 and DC13, that have previously
FIG 1 IE serological conservation correlates with parasite var gene expression profiles but not host malaria severity. Eight pools of serum samples, each
composed of serum samples from 100 malaria parasite-exposed Kenyan children, were tested for IgG antibodies against each of 92 clinical isolates using IFA. (a)
The mean fluorescence intensity (MFI) for each pool is shown. Pools 1, 3, 5, and 7 represent pools of serum samples from parasite-negative children aged 1, 2,
3, and 4 years, respectively, and MFIs are indicated as gray dots. Pools 2, 4, 6, and 8 represent pools of serum samples from parasite-positive children aged 1, 2,
3, and 4 years, respectively, and MFIs are indicated as black dots. (b) Spearman’s rank correlation coefficients are shown for the relationship between the levels
of parasite expression of various var gene subsets and recognition of the corresponding IEs by antibodies in each of the 8 serum sample pools. Gray and black dots,
correlations calculated from antibodies from the parasite-negative and parasite-positive pools, respectively. The correlation coefficients and P values of the
association between each var subset and responses in each serum sample pool are presented in Table S1 in the supplemental material. (c and d) Odds ratios, 95%
confidence intervals, and P values (*, P 0.05; **, P 0.01; ***, P 0.001) from unadjusted logistic regression models predicting the association of host disease
severity with either the recognizability of parasites by the serum sample pools (levels of IgG antibody to IEs), where odds ratios are presented per 100 MFI units
(c), or parasite var expression levels (d). In these models, recognition by each serum sample pool (c) or the expression levels of each var gene subset (d) are used
in turn as continuous variables.
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been found to correlate with disease severity (18). Our expectation
was that recognition of IE by antibodies in the serum sample
pools, parasite var gene expression, and host disease severity
would be correlated.
Expression of all var gene groups previously associated with
severe malaria (15, 18, 19, 27) showed an association with the
strength of recognition of IEs by at least one serum sample pool at
the conventional cutoff for statistical significance (Spearman’s
rank correlation, P 0.05) (Fig. 1b; see also Table S1 in the sup-
plemental material). However, of these associations, only group A
var expression, as measured by determination of Cys2 expression
levels (15) and transcript abundance with primer DBLa1 not var3,
and DC8 expression, as measured with primer DBLa_CIDRa and
primers DBLb12 and DBLb3/5, met our threshold for statistical
significance (Spearman’s rank correlation, P  0.0005) on the
basis of a Bonferroni correction for the 104 comparisons per-
formed (Fig. 1b; see also Table S1 in the supplemental material).
Overall, this was consistent with previous evidence that antibodies
from P. falciparum-exposed individuals frequently recognize
group A and DC8 PfEMP1 variants (7, 14, 18, 21).
As previously reported from studies that used this data set,
there were positive associations between severe malaria and ex-
pression of several of the var gene subsets considered here, with
group A var expression showing the strongest associations (Fig.
1d) (15, 19, 27). However, in contrast to previous studies with
antibodies sampled closer in time to the time of parasite sampling
(3, 4, 6), we found no evidence for a significant difference between
the ability of IEs causing severe malaria and those causing nonse-
vere malaria to be recognized by antibodies whether recognition
by antibodies from serum sample pools (Fig. 1c) or in the panel of
plasma samples was measured (see Data Set S1 in the supplemen-
tal material).
Where enough sample material was available (n 59 samples,
29 of which were from children with severe malaria), we addition-
ally typed the parasites by an agglutination assay, which was gen-
erally less sensitive than flow cytometry, and only two pools had
detectable responses to 50% of the isolates (see Fig. S1 in the
supplemental material). Nevertheless, the agglutination score
showed positive associations with DC8 var subsets at the conven-
tional level of statistical significance of a P value of0.05, though
these did not meet the cutoff for statistical significance after a
Bonferroni adjustment for multiple comparisons was made (see
Table S2 in the supplemental material). The agglutination score
did not differ by disease severity whether it was measured in the
panel of plasma samples or the serum sample pools (Mann-Whit-
ney U test, P  0.05 for all comparisons; see Data Set S1 in the
supplemental material).
A plausible explanation for our observations is that whereas
previous studies used a relatively short time interval of up to 3
years between the time of sampling of naturally acquired antibod-
ies and the time of sampling of target IE, this study used a 10- to
12-year time interval. This raises the possibility that, while group
A and DC8 var genes tend to be expressed mostly in immunolog-
ically naive individuals and the PfEMP1 variants expressed by
these genes carry epitopes that are conserved over long periods,
the variants that actually cause severe malaria may be prevalent
over relatively short periods of a few years but then break apart
through var gene recombination (31). This interpretation would
emphasize an important role of immune evasion in parasite viru-
lence. It should now be relatively straightforward to test this in
studies specifically designed to explore antibody recognition of
parasites causing severe malaria using different time periods be-
tween the time of collection of the sera and parasites.
In summary, by measuring var gene expression levels, we have
found evidence that group A and DC8 PfEMP1 variants, whose
bulk expression correlates with the severity of malaria, have re-
stricted antigenic diversity. However, we found no evidence for an
association between the serological conservation of IE antigens per
se and severe malaria. These data contrast with the working hy-
pothesis that severe malaria is caused byP. falciparum isolates with
PfEMP1 variants whose immunodominant epitopes are main-
tained over long time periods. Further studies are needed to de-
termine the rate of turnover within the local parasite population of
PfEMP1 variants associated with severe malaria.
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